BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

Reuters
17 Apr
BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

April 17 (Reuters) - Nurix Therapeutics Inc NRIX.O:

  • NURIX ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR GS-6791/NX-0479 - A NOVEL IRAK4 DEGRADER FOR INFLAMMATORY CONDITIONS

  • NURIX THERAPEUTICS INC - GILEAD TO BEGIN PHASE 1 STUDY IN Q2 2025

  • NURIX THERAPEUTICS INC - TO RECEIVE $5 MILLION MILESTONE PAYMENT FROM GILEAD

  • NURIX THERAPEUTICS INC - ELIGIBLE FOR $420 MILLION IN FUTURE MILESTONES

Source text: ID:nGNX9p7cxX

Further company coverage: NRIX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10